Global Pharmaceuticals & Biotech Mid-Large Cap Stocks

Camurus

Market Cap: SEK 29.7b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Danaher

Market Cap: US$134.2b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

United Therapeutics

Market Cap: US$13.9b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Mettler-Toledo International

Market Cap: US$23.6b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

CG Oncology

Market Cap: US$2.0b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

HUTCHMED (China)

Market Cap: UK£1.8b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

MoonLake Immunotherapeutics

Market Cap: US$2.4b

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Bausch Health Companies

Market Cap: US$1.7b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Exact Sciences

Market Cap: US$10.7b

Provides cancer screening and diagnostic test products in the United States and internationally.

Viridian Therapeutics

Market Cap: US$1.1b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Galderma Group

Market Cap: CHF 24.3b

Operates as a dermatology company worldwide.

Sartorius Stedim Biotech

Market Cap: €18.6b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Regeneron Pharmaceuticals

Market Cap: US$63.1b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Polaris Group

Market Cap: NT$31.1b

Offers biotechnology, drug testing, and contract development and manufacturing services.

MGI Tech

Market Cap: CN¥30.4b

Engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries.

Celltrion Pharm

Market Cap: ₩2.0t

A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.

Shanghai Henlius Biotech

Market Cap: HK$22.9b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

GNI Group

Market Cap: JP¥149.2b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

PharmaEssentia

Market Cap: NT$166.9b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

SK Biopharmaceuticals

Market Cap: ₩7.0t

A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.

Sinocelltech Group

Market Cap: CN¥17.5b

A biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China.

ABL Bio

Market Cap: ₩3.1t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Emcure Pharmaceuticals

Market Cap: ₹243.4b

Engages in the developing, manufacturing, and marketing pharmaceutical products worldwide.

Caliway Biopharmaceuticals

Market Cap: NT$137.0b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Mankind Pharma

Market Cap: ₹1.0t

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.

ALTEOGEN

Market Cap: ₩17.2t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Hugel

Market Cap: ₩3.8t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Neuren Pharmaceuticals

Market Cap: AU$1.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

RemeGen

Market Cap: HK$31.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

Duality Biotherapeutics

Market Cap: HK$18.8b

Duality Biotherapeutics Inc., a clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

Hansoh Pharmaceutical Group

Market Cap: HK$152.5b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Luye Pharma Group

Market Cap: HK$8.3b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

Oxford Nanopore Technologies

Market Cap: UK£1.2b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

Innoviva

Market Cap: US$1.2b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

Vera Therapeutics

Market Cap: US$1.3b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.